Regenerative Medicine Highlights: July – September 2024
Journal Development Editor, Jasmine Hagan, shares her top papers from the July, August and September issues of Regenerative Medicine.
In the past quarter, we highlighted exciting developments in the field of regenerative medicine, exploring a variety of topics such as the adoption of advanced therapy medicinal products in healthcare systems, the development of stem cell therapies and novel strategies in liver tissue engineering.
In this feature, I share some of my top articles from issues 7, 8 and 9 of Volume 19, providing a snapshot of some of the most exciting work in the field, published in Regenerative Medicine.
Patient, parent and professional expert perspectives on personalized regenerative implants: a qualitative focus group study
Personalised regenerative implants have emerged as a promising innovation in development, aiming to advance the field of regenerative medicine through a tailored approach. With potential applications in musculoskeletal diseases, the premise of these implants relies on their ability to facilitate cell growth by serving as scaffolds for tissue repair and regeneration. The implants are capable of breaking down in the body, gradually being replaced with living tissue. The development and use of these implants raises a number of considerations, including ethical challenges, safety and effectiveness, and stakeholder perceptions. To understand how well personalized regenerative implants are perceived within the community the authors examined the views of key stakeholders, including patients, engineers and clinicians. The study included a cohort of 29 individuals who participated in a virtual focus group.
A key theme that emerged from the focus group was the importance of patient-centred research and care, emphasising the need to move beyond a sole focus on the technical and clinical aspects of the implants, and instead, to place greater recognition on its impact on patients and their quality of life. The authors also noted varying views among stakeholders regarding the use of the implants as new biotechnology tool and the associated costs. They also noted support for the personalised approach, was seen as a way of improving care by tailoring treatment to individual needs. The study provides valuable insights into the importance of patient-centred care and research in regenerative medicine, helping to propel the field in the right direction.
Unconventional strategies for liver tissue engineering: plant, paper, silk and nanomaterial-based scaffolds
In tissue engineering, scaffolds are 3D structures, typically made from polymeric biomaterials, that mimic the extracellular matrix and provide favourable conditions for cell adhesion and growth. As the demand for easily available, sustainable and economical biomaterials continues to grow, scientists are becoming increasingly interested in identifying unconventional biomaterials that can overcome these limitations.
In this review, the authors explore the potential of alternative materials such as plants, silk and paper for use in scaffolds for liver tissue engineering strategies. These materials not only offer a cost-effective, sustainable and easily accessible alternative to polymeric biomaterials, but also possess favourable properties that make them useful for hepatic regeneration and modeling. While further research is needed to fully assess the safety and efficacy of these unconventional scaffolds, they serve as promising alternatives to polymeric biomaterials.
Induced pluripotent stem cell therapies in heart failure treatment: a meta-analysis and systematic review
With heart failure remaining a leading cause of morbidity and mortality, there is increasing interest in harnessing the potential of stem cells to develop therapies that could improve outcomes for patients. This meta-analysis and systematic review examines the current evidence on iPSC-based therapies for heart failure and assesses their effectiveness in improving outcomes. The researchers’ approach involved analyzing 25 studies with a combined total of 553 animal models to evaluate improvements in heart function following treatment. Notably, across the studies, the team observed improved left ventricular function following iPSC therapy. They also noted reduced fibrosis and cardiac modeling, suggesting significant improvements in overall cardiac function. While further research is needed, the study highlights the potential of iPSC-based therapies for improving treatment strategies in patients with heart failure.
Don’t forget to read Jasmine’s previous journal highlights here >>>
If you have any queries about Regenerative Medicine or are interested in publishing in the journal, please contact Journal Development Editor, Jasmine Hagan ([email protected]).
